Oligomerization of family B GPCRs: Exploration in inter-family oligomer formation

Frontiers in Endocrinology

Volumn 6, Issue FEB, 2015, Pages

  Ng, Hans K H ^a   Chow, Billy K C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Family B; GPCR; GPCR oligomerization; Heteromer; Homomer

Indexed keywords

4 AMINOBUTYRIC ACID; ANGIOTENSIN 1 RECEPTOR; CHOLECYSTOKININ A RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; GROWTH HORMONE RELEASING HORMONE RECEPTOR; HORMONE RECEPTOR; OLIGOMER; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RECEPTOR 2; PHOSPHOLIPASE C; RENILLA LUCIFERIN 2 MONOOXYGENASE; SECRETIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

CENTRAL NERVOUS SYSTEM; DRINKING BEHAVIOR; FLUORESCENCE RESONANCE ENERGY TRANSFER; GASTRINOMA; HUMAN; HYPEROSMOLALITY; LIGAND BINDING; NONHUMAN; OLIGOMERIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 84926672461     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00010     Document Type: Short Survey

References (42)

1. Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J (1999) 18:1723-9. doi: 10.1093/emboj/18.7.1723
2. Kolakowski LF Jr. GCRDb: a G-protein-coupled receptor database. Receptors Channels (1994) 2:1-7.
3. Harmar AJ. Family-B G-protein-coupled receptors. Genome Biol (2001) 2:reviews3013. doi:10.1186/gb-2001-2-12-reviews3013
4. Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther (2004) 103:21-80. doi:10.1016/j.pharmthera.2004.05.002
5. Kenakin T, Miller LJ. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev (2010) 62:265-304. doi:10.1124/pr.108.000992
6. Fraser CM, Venter JC. The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. Biochem Biophys Res Commun (1982) 109:21-9. doi:10.1016/0006-291X(82)91560-1
7. Ding WQ, Cheng ZJ, McElhiney J, Kuntz SM, Miller LJ. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res (2002) 62:5223-9.
8. Harikumar KG, Morfis MM, Lisenbee CS, Sexton PM, Miller LJ. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors. Mol Pharmacol (2006) 69:363-73. doi:10.1124/mol.105.015776
9. Harikumar KG, Morfis MM, Sexton PM, Miller LJ. Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor. J Mol Neurosci (2008) 36:279-85. doi:10.1007/s12031-008-9060-z
10. Orgaard A. Binding and Dimerization Studies on the Glucagon Receptor. Copenhagen: University of Copenhagen (2011).
11. Roed SN. Receptor Dimerization and Binding Profile of the Incretin Glucagon-Like Peptide-1. Copenhagen: University of Copenhagen (2011).
12. Schelshorn DW, Joly F, Mutel S, Hampe C, Breton B, Mutel V, et al. Lateral allosterism in the glucagon receptor family: GLP-1 induces GPCR heteromer formation. Mol Pharmacol (2011) 81:309-18. doi:10.1124/mol.111.074757
13. Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep (2004) 5:30-4. doi:10.1038/sj.embor.7400052
14. Lee LTO, Ng SYL, Chu JYS, Sekar R, Harikumar KG, Miller LJ, et al. Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex. FASEB J (2014) 28:2632-44. doi:10.1096/fj.13-246868
15. Venter JC, Horne P, Eddy B, Greguski R, Fraser CM. Alpha 1-adrenergic receptor structure. Mol Pharmacol (1984) 26:196-205.
16. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC. Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J Biol Chem (2000) 275:7862-9. doi:10.1074/jbc.275.11.7862
17. Vassart G. An demonstration of functional G protein-coupled receptor dimers. Proc Natl Acad Sci U S A (2010) 107:1819-20. doi:10.1073/pnas.0914432107
18. Latif R, Graves P, Davies TF. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem (2002) 277:45059-67. doi:10.1074/jbc.M206693200
19. Redka DS, Heerklotz H, Wells JW. Efficacy as an intrinsic property of the M2 muscarinic receptor in its tetrameric state. Biochemistry (2013) 52:7405-27. doi:10.1021/bi4003869
20. Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, et al. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J (2001) 20:2152-9. doi:10.1093/emboj/20.9.2152
21. Comps-Agrar L, Kniazeff J, Norskov-Lauritsen L, Maurel D, Gassmann M, Gregor N, et al. The oligomeric state sets GABA (B) receptor signalling efficacy. EMBO J (2011) 30:2336-49. doi:10.1038/emboj.2011.143
22. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, et al. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem (1996) 271:16384-92. doi:10.1074/jbc.271.27.16384
23. Hamdan FF, Percherancier Y, Breton B, Bouvier M. Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET). Curr Protoc Neurosci (2006) 5(Unit 5):23. doi:10.1002/0471142301.ns0523s34
24. Pfleger KDG, Eidne KA. Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods (2006) 3:165-9. doi:10.1038/nmeth841
25. Ayoub MA, Pfleger KD. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr Opin Pharmacol (2010) 10:44-52. doi:10.1016/j.coph.2009.09.012
26. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol (2010) 6:587-94. doi:10.1038/nchembio.396
27. Vidi PA, Ejendal KF, Przybyla JA, Watts VJ. Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. Mol Cell Endocrinol (2011) 331:185-93. doi:10.1016/j.mce.2010.07.011
28. Ishihara T, Nakamura S, Kaziro Y, Takahashi T, Takahashi K, Nagata S. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J (1991) 10:1635-41.
29. Harikumar KG, Pinon DI, Miller LJ. Transmembrane segment IV contributes a functionally important interface for oligomerization of the class II G protein-coupled secretin receptor. J Biol Chem (2007) 282:30363-72. doi:10.1074/jbc.M702325200
30. Lisenbee CS, Miller LJ. Secretin receptor oligomers form intracellularly during maturation through receptor core domains. Biochemistry (2006) 45:8216-26. doi:10.1021/bi060494y
31. Pioszak AA, Harikumar KG, Parker NR, Miller LJ, Xu HE. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. J Biol Chem (2010) 285:12435-44. doi:10.1074/jbc.M109.093138
32. McElvaine AT, Mayo KE. A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology (2006) 147:1884-94. doi:10.1210/en.2005-1488
33. Seck T, Baron R, Horne WC. The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. J Biol Chem (2003) 278:23085-93. doi:10.1074/jbc.M211280200
34. Heroux M, Breton B, Hogue M, Bouvier M. Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET. Biochemistry (2007) 46:7022-33. doi:10.1021/bi0622470
35. Kraetke O, Wiesner B, Eichhorst J, Furkert J, Bienert M, Beyermann M. Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding. J Recept Signal Transduct Res (2005) 25:251-76. doi:10.1080/10799890500468838
36. Young S, Griffante C, Aguilera G. Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell Mol Neurobiol (2007) 27:439-61. doi:10.1007/s10571-006-9135-8
37. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods (2008) 5:561-7. doi:10.1038/nmeth.1213
38. Schelshorn D, Joly F, Mutel S, Hampe C, Breton B, Mutel V, et al. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation. Mol Pharmacol (2012) 81:309-18. doi:10.1124/mol.111.074757
39. Harikumar KG, Wootten D, Pinon DI, Koole C, Ball AM, Furness SG, et al. Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery. Proc Natl Acad Sci U S A (2012) 109:18607-12. doi:10.1073/pnas.1205227109
40. Vohra S, Chintapalli SV, Illingworth CJ, Reeves PJ, Mullineaux PM, Clark HS, et al. Computational studies of family A and family B GPCRs. Biochem Soc Trans (2007) 35:749-54. doi:10.1042/BST0350749
41. Vrecl M, Drinovec L, Elling C, Heding A. Opsin oligomerization in a heterologous cell system. J Recept Signal Transduct Res (2006) 26:505-26. doi:10.1080/10799890600932253
42. Lee VHY, Lee LTO, Chu JYS, Lam IPY, Siu FKY, Vaudry H, et al. An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II. FASEB J (2010) 24:5024-32. doi:10.1096/fj.10-165399